Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer

NCT07195227 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hormon Receptor Positive Breast Cancer
Breast Cancer

Interventions

DRUG: Camizestrant
DRUG: Ribociclib

Sponsor

MedSIR